KCT0007061招募中未知
Safety of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20?(Year) 至 80?(Year)（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •- Pathologically diagnosed as gastric adenocarcinoma
- •- Imaging scans or diagnostic laparoscopic findings suggestive of peritoneal metastasis
- •- Patients set to undergo FOLFOX as systemic chemotherapy regimen after a multidisciplinary meeting
- •- Laboratory tests adequate for chemotherapy (within 2 weeks of enrollment)
- •- Absolute Neutrophil Count: ? 1,500/mm³
- •- Hemoglobin level: ? 8.0g/dL
- •- Platelet Count: ? 10×104/mm³
- •- AST (GOT), ALT (GPT): ? 100U/L
- •- Total Bilirubin: ? 2.0mg/dL
- •- Creatinine Clearance (CCl): ? 50mL/min
- •- ECOG 0 - 2
- •- HER-2 negative tumor
- •- age of or over 20 and less than 80 years
- •- agreed to the informed consent
排除标准
- •Exclusion Criteria:
- •- Patients with other major medical disease or malignant tumors other than gastric cancer
- •- Contraindication to 5-FU, Oxaliplatin, Leukovorin or Paclitaxel
- •- Pregnant, breast-feeding women or with birth plan
- •- Patients refusing treatment
- •- Patients who are totally dependent on parenteral nutrition
- •- Having allergies to anticancer agents
- •- Who have anticipated lifespan of less than 3 months
- •- Small bowel ileus
- •- Distant metastasis in other organs (except lymph nodes and Krukenberg/ovaries)
研究者
相似试验
进行中（未招募）
1 期
Pilot study on intraperitoneal chemotherapy delivered via aerosol in patients with peritoneal carcinomatosisPeritoneal carcinomatosisMedDRA version: 20.0Level: LLTClassification code 10068069Term: Peritoneal carcinomatosisSystem Organ Class: 100000004864EUCTR2020-000560-37-ITISTITUTO ONCOLOGICO VENETO - IRCCS25
Unknown
1 期
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal MetastasisStomach NeoplasmPeritoneal MetastasesNCT04913662Seoul National University Bundang Hospital18
进行中（未招募）
1 期
Can Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) reduce the risk of recurrence after colon resection for colon cancer?Recurrence after resection for colon cancerMedDRA version: 20.0Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-002637-37-DKKirurgisk Afdeling A, Odense Universitetshospital60
招募中
3 期
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial. PIPAC_VEROne2024-515981-14-00Azienda Ospedaliera Universitaria Integrata Verona98
进行中（未招募）
1 期
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy in women with advanced ovarian cancerCTIS2024-515996-37-00Hospices Civils De Lyon15